Back to Newsroom

Conatus Pharmaceuticals to Report Third Quarter 2016 Financial Results

SAN DIEGO, Nov. 01, 2016 (GLOBE NEWSWIRE) — Conatus Pharmaceuticals Inc. (Nasdaq:CNAT), a biotechnology company focused on the development and commercialization of novel medicines to treat liver disease, today announced that it will report financial results for the third quarter ended September 30, 2016, after the market close on Tuesday, November 8, 2016. Conatus will host a conference call and audio webcast at 4:30 p.m. Eastern Time on Tuesday, November 8, 2016, to discuss the financial results and provide a corporate update.

Click here to read the full release